Simtuzumab
Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2) . Simtuzumab can be used to treat primary sclerosing cholangitis (PSC) and is not effective in patients with bridging fibrosis or compensatory cirrhosis caused by non-alcoholic steatohepatitis.
Product Specifications
CAS Number
1318075-13-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Monoamine Oxidase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15339075 1 Vial
Lentiviral human IFRD2 shRNA (UAS) - Lentiviral human IFRD2 shRNA (UAS, RFP) (100)
Ask
View Details 